Regenstrief Institute, Inc., Indianapolis, IN, USA.
Purdue University College of Pharmacy, West Lafayette, IN, USA.
J Gen Intern Med. 2018 Apr;33(4):455-462. doi: 10.1007/s11606-017-4281-x. Epub 2018 Jan 12.
African Americans are especially at risk of hypertension and dementia. Antihypertensive medications reduce the risk of cardiovascular events, but may also reduce the risk of dementia.
To assess the longitudinal effects of antihypertensive medications and blood pressure on the onset of incident dementia in a cohort of African Americans.
Prospective cohort.
1236 community-dwelling patients from an inner-city public health care system, aged 65 years and older, with a history of hypertension but no history of dementia, and who had at least three primary care visits and a prescription filled for any medication.
Blood pressure was the average of three seated measurements. Dementia was diagnosed using a two-stage design, with a screening evaluation every 2 to 3 years followed by a comprehensive in-home clinical evaluation for those with a positive screen. Laboratory, inpatient and outpatient encounter data, coded diagnoses and procedures, and medication records were derived from a health information exchange.
Of the 1236 hypertensive participants without dementia at baseline, 114 (9%) developed incident dementia during follow-up. Individuals prescribed any antihypertensive medication (n = 816) were found to have a significantly reduced risk of dementia (HR = 0.57, 95% CI 0.37-0.88, p = 0.0114) compared to untreated hypertensive participants (n = 420). When this analysis was repeated including a variable indicating suboptimally treated blood pressure (> 140 mmHg systolic or >90 mmHg diastolic), the effect of antihypertensive medication was no longer statistically significant (HR = 0.65, 95% CI 0.32-1.30, p = 0.2217).
Control of blood pressure in older adult African American patients with hypertension is a key intervention for preventing dementia, with similar benefits from most of the commonly available antihypertensive medications.
非裔美国人尤其面临高血压和痴呆的风险。抗高血压药物可降低心血管事件的风险,但也可能降低痴呆的风险。
在非裔美国人队列中评估抗高血压药物和血压对新发痴呆症发病的纵向影响。
前瞻性队列研究。
来自城市内公共医疗保健系统的 1236 名社区居住的患者,年龄在 65 岁及以上,有高血压病史但无痴呆病史,至少有三次初级保健就诊和开处方的任何药物。
血压为三次坐姿测量的平均值。痴呆症采用两阶段设计进行诊断,每 2 至 3 年进行一次筛查评估,对筛查阳性者进行全面的家庭临床评估。实验室、住院和门诊就诊数据、编码诊断和程序以及药物记录均来自健康信息交换。
在基线时无痴呆症的 1236 名高血压参与者中,有 114 名(9%)在随访期间发生了新发痴呆症。与未接受治疗的高血压参与者(n=420)相比,服用任何抗高血压药物的患者(n=816)发生痴呆症的风险显著降低(HR=0.57,95%CI 0.37-0.88,p=0.0114)。当将表明血压控制不佳(收缩压>140mmHg 或舒张压>90mmHg)的变量纳入此分析时,抗高血压药物的作用不再具有统计学意义(HR=0.65,95%CI 0.32-1.30,p=0.2217)。
控制老年非裔美国高血压患者的血压是预防痴呆的关键干预措施,大多数常用的抗高血压药物都有类似的益处。